CNTX
Context Therapeutics Inc.
0.61
2 x 0.43
2 x 0.74
bid
ask
+
0.00
0.00%
2 @ 08:58 AM
0.61 -0.00 (0.05%)
Ytd-58.62%
1y-3.14%
day range
0.55
52 week range
3.62
OpenPrev Close0.61LowHighMkt Cap55.89M
Vol0.00Avg Vol1.87MEPS-0.42P/EN/AForward P/E-3.38
Beta2.25Short Ratio2.79Inst. Own76.40%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning05-0750-d Avg1.87200-d Avg1.771yr Est7.70
Income Statement
Operating Expenses9.20M
Research and Development Expense7.02M
Selling, General and Administrative Expense2.33M
Operating Income-9.20M
Net Income-8.68M
Net Income Common Stock-8.68M
Net Income Common Stock (USD)-8.68M
Consolidated Income-8.68M
Earnings per Basic Share-0.09
Earnings per Basic Share (USD)-0.09
Earnings per Diluted Share-0.09
Earning Before Interest & Taxes (EBIT)-8.68M
Earning Before Interest & Taxes (USD)-8.68M
Weighted Average Shares95.18M
Weighted Average Shares Diluted95.18M
Balance Sheet
Cash and Equivalents54.53M
Cash and Equivalents (USD)54.53M
Current Assets58.52M
Property, Plant & Equipment Net342.28K
Total Assets58.86M
Debt Current160.06K
Total Debt282.42K
Current Liabilities6.53M
Debt Non-Current122.37K
Total Liabilities6.66M
Accumulated Retained Earnings (Deficit)-139.58M
Shareholders Equity52.20M
Shareholders Equity (USD)52.20M
Assets Non-Current342.28K
Total Debt (USD)282.42K
Liabilities Non-Current122.37K
Trade and Non-Trade Payables2.47M
Cash Flow
Depreciation, Amortization & Accretion36.10K
Net Cash Flow / Change in Cash & Cash Equivalents-11.47M
Capital Expenditure-37.26K
Net Cash Flow from Investing-37.26K
Net Cash Flow from Operations-11.43M
Share Based Compensation409.22K